(Reuters) - Using blood plasma from COVID-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released on Tuesday from a clinical trial in Argentina. The therapy know as convalescent ...
from Google Alert - health https://ift.tt/2V2x3Gs
via IFTTT
0 comments:
Post a Comment